Sanofi, Mucosolvan cough syrup, 100

Mucosolvan in syrup is used for infections of the lungs and bronchi that expand due to the accumulation of sticky mucous secretion. The preparation is helpful in the autumn-winter period, when viral infections of the body that attack the upper respiratory tract most often occur. Ambroxol, which is the active substance of this medicinal preparation, is helpful in wet cough, colds and in the flu season.

Using Mucosolvan syrup

Mucosolvan is a medicinal preparation in the form of a syrup, effectively relieving cough, which is accompanied by difficulties in expectorating retained secretions. Mucosolvan belongs to the group of mucolytic and mucoregulatory drugs. This means that the complex structure of the residue affects substances secreted by the bronchi. The substance responsible for the mucolytic properties of Mucosolvan is ambroxol. It acts polyvalently (in different directions), on the cause of cough, i.e. by thinning the mucus, which leads to easier expectoration and removal of retained secretions from the lungs. Additionally, the preparation actively regulates its secretion and supports its transport, and as a result completely combats wet cough.

When to use Mucosolvan syrup?

Mucosolvan syrup is a medicinal product that is most effective in cases of lung and bronchial infections and in cold and flu conditions, when there is persistent, expanding retention of sticky mucus secretions. The drug relieves symptoms, reducing the feeling of chest pain and minimizing the cough reflex, eventually eliminating it completely.
Another great advantage of Mucosolvan is its form. The viscous syrup makes it not only easy to swallow. The thick liquid soothes throat irritations that occur as a result of coughing and covers the upper respiratory tract with a layer that facilitates expectoration and swallowing. The product helps successively, day by day, soothing the cough and minimizing its attacks. It is also helpful at night, when the number of wake-ups caused by a wet cough decreases.
 

Indications

Acute and chronic diseases of the lungs and bronchi associated with impaired mucus secretion and impaired its transport.